Byline Bancorp, Inc. (BY)
NYSE: BY · Real-Time Price · USD
31.91
0.00 (0.00%)
Apr 2, 2026, 4:00 PM EDT - Market closed

Byline Bancorp Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
149.1563.14226.14179.35157.93
Securities and Investments
1,4371,4541,3691,2131,491
Gross Loans
7,5096,9076,6845,4214,537
Allowance for Loan Losses
-108.83-97.99-101.69-81.92-55.01
Net Loans
7,4016,8096,5835,3394,482
Net Property, Plant & Equipment
67.0270.379.168.1574.19
Accrued Interest and Accounts Receivable
39.8240.6543.9229.8218.88
Other Intangible Assets
37.935.3541.6229.7140.95
Goodwill
181.85181.71181.71148.35148.35
Other Non-Earning Assets
339.37342.94358.18354.9282.75
Total Assets
9,6539,4978,8827,3636,696
Interest-bearing deposits
5,8295,7035,2713,5562,997
Noninterest-bearing deposits
1,8191,7561,9062,1392,158
Total Deposits
7,6477,4597,1775,6955,155
Short-Term Interbank Borrowing and Repurchase Agreements
419.6607.11365.61640.4519.72
Short-Term Borrowings
--11.25--
Accrued Expenses
172.38182.7175.31150.5874.6
Long-Term Debt
145.35156.6162.65111.03110.42
Total Liabilities
8,3858,4057,8926,5975,860
Preferred Stock
----10.44
Common Stock
0.470.460.450.390.39
Treasury Stock
-65.91-46.94-49.71-51.11-31.57
Additional Paid-in Capital
760.7717.76710.49598.3593.75
Accumulated Other Comprehensive Income
-73.08-113.69-100.12-117.55-8.3
Retained Earnings
645.72533.9429.04335.79271.68
Shareholders' Equity
1,2681,091990.15765.82836.38
Total Liabilities & Equity
9,6539,4978,8827,3636,696
Total Debt
145.35156.6162.65111.03110.42
Net Cash (Debt)
-145.35-156.6-162.65-111.03-110.42
Net Cash Per Share
-3.23-3.57-4.02-2.96-2.88
Book Value
1,2681,091990.15765.82836.38
Book Value Per Share
28.1424.8924.4820.4321.80
Tangible Book Value
1,048874.45766.83587.76647.08
Tangible Book Value Per Share
23.2619.9418.9615.6816.86
Updated Dec 31, 2025. Data Source: Fiscal.ai. Banks template. Financial Sources.
SEC Filings: 10-K · 10-Q